SCHEMBL2960299

SCHEMBL2960299

COc1cc(C2CCc3c(O)cc(O)cc3O2)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.61
CYP1A2 P05177 2/20 0.61
CYP1B1 Q16678 2/20 0.61
POLB P06746 1/20 0.61
PTPN1 P18031 2/20 0.55
CYP19A1 P11511 3/20 0.52
TP53 P04637 2/20 0.52
CYP3A4 P08684 2/20 0.52
XDH P47989 2/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PKM P14618 1/20 0.52
NPC1 O15118 1/20 0.52
CA12 O43570 1/20 0.52
KDM1A O60341 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22422561 0.93 CYP19A1 (0.55) CYP1A1CYP1A2CYP1B1POLBPTPN1
SCHEMBL2970150 0.91 CYP19A1 (0.56) CYP1A1CYP1A2CYP1B1POLBPTPN1
SCHEMBL2968452 0.91 CYP19A1 (0.62) CYP1A1CYP1A2CYP1B1POLBPTPN1
SCHEMBL8247927 0.84 KDM4E (0.57) CYP1A1CYP1A2CYP1B1POLBCYP19A1
SCHEMBL2595124 0.84 KDM4E (0.57) CYP1A1CYP1A2CYP1B1POLBCYP19A1
SCHEMBL30468829 0.84 KDM4E (0.57) CYP1A1CYP1A2CYP1B1POLBCYP19A1
SCHEMBL18427306 0.84 KDM4E (0.57) CYP1A1CYP1A2CYP1B1POLBCYP19A1
SCHEMBL8243518 0.84 KDM4E (0.57) CYP1A1CYP1A2CYP1B1POLBCYP19A1
SCHEMBL31053922 0.84 CYP19A1 (0.50) CYP1A1CYP1A2CYP1B1POLBPTPN1
SCHEMBL2956557 0.84 CYP19A1 (0.56) CYP1A1CYP1A2CYP1B1POLBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2253226-B1 Use of hydroxyflavone derivatives for modifying taste LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) 2015-07-15 EP claimed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP claimed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US claimed
WO-2017208058-A1 HIGH POLYPHENOLS COCOA POWDER BASED PRODUCTS, USES AND METHODS FOR THE MANUFACTURE THEREOF CASALUKER S.A. (CO) 2017-12-07 WO disclosed
EP-2253226-B1 Use of hydroxyflavone derivatives for modifying taste LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) 2015-07-15 EP disclosed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP disclosed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION TAS2R50, TAS2R60, TAS2R30 CYP1A1 2369/4885CYP1A2 2000/4885CYP1B1 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.